On October 16-18, 2023, HGPI Chairman Dr. Kiyoshi Kurokawa, CEO and Board Member Mr. Ryoji Noritake, and Vice President Mr. Joji Sugawara spoke at various programs throughout each day of the 10th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-sponsored by Financial Times.

For details, please visit the event website, which can be found here.

 

Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake, Mr. Sugawara.

 

October 17 (Tue)

Special Session 1 Establishing a Drug Discovery Ecosystem for Infectious Disease Area – A Year in Review and Future Initiatives –

Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)

Special Session 2 Importance of Novel Antibacterial Drugs, and Global Collaboration for Expansion of Necessary Pull-type Incentives

Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)

Agenda 4 – Making Unpredictable Communicable Disease Predictable by Economic Incentives and R&D

Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)

Breakout Session D Significance and Challenges of Infectious Diseases Control in Companies

Discusser: Joji Sugawara (Vice President, Health and Global Policy Institute)

 

October 18 (Wed)

Special Session 4 Making Breakthroughs With Japan -Toward Accelerating Open Innovation in Japan-

Moderator: Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)

Summary Session / Conclusion / Statement

Panelist:
Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
Ryoji Noritake (CEO and Board Member, Health and Global Policy Institute)